Wegovy vs Mounjaro: UK Pricing & Availability Comparison
Is Wegovy Cheaper Than Mounjaro for UK Patients?
The cost comparison between Wegovy and Mounjaro varies significantly depending on your chosen provider and dosing schedule. Wegovy's transparent pricing structure starts at £79.99 for the initial 0.25mg pen, progressing through clearly defined dose escalations to the maintenance 2.4mg dose at £209.99. This predictable pricing allows patients to budget effectively throughout their treatment journey. Mounjaro pricing often involves complex subscription models with varying monthly fees that can make direct cost comparison challenging for patients seeking clarity on their investment.
When evaluating whether Wegovy is cheaper than Mounjaro, consider the total treatment cost over time rather than just initial pricing. Wegovy's dose escalation follows a structured 16-week progression, allowing patients to understand their complete financial commitment upfront. Our Getting Started bundles, such as the Intro Duo combining 0.25mg and 0.5mg pens for £169.99, provide cost-effective options for beginning treatment. Additionally, discount codes FIRST40 for new customers and DOSE25 for returning patients are applied at checkout to reach these competitive prices.
Wegovy Pricing Structure & Bundle Savings
Understanding the complete Wegovy pricing structure helps determine whether Wegovy is cheaper than Mounjaro for your specific needs. Individual pen prices range from £79.99 (0.25mg starter) to £209.99 (2.4mg maintenance), with intermediate doses at £94.99 (0.5mg), £99.99 (1mg), and £139.99 (1.7mg). Our bundle options provide convenience and supply security, with the Progress Trio (0.5mg, 1mg & 1.7mg) available for £369.99, covering weeks 5-16 of treatment. For patients reaching maintenance dose, the Ultimate Stability Trio provides three 2.4mg pens for £649.99.
The 2-pen Getting Started bundles offer seamless dose progression without multiple orders. The Progress Duo (0.5mg & 1mg) costs £189.99, whilst the Advance Duo (1mg & 1.7mg) is priced at £269.99. Consistency bundles provide duplicate doses for patients who tolerate specific strengths well, such as Consistency 1mg (×2) for £209.99. All pricing includes clinical assessment, prescriber review by our GPhC #9012878 registered team, and next-day cold-chain delivery once approved.
Clinical Evidence: Wegovy vs Mounjaro Efficacy
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), compared to 2.4% with placebo. The STEP programme demonstrated consistent results across diverse patient populations, with STEP 2 showing clinically studied weight loss in patients with type 2 diabetes and STEP 3 achieving 16% when combined with intensive behavioural therapy. These results support Wegovy's efficacy as part of comprehensive weight management programmes.
Mounjaro (tirzepatide) showed different results in its SURMOUNT trials, but direct comparison of trial data isn't appropriate due to different study designs, patient populations, and endpoints. Both medications have demonstrated significant efficacy in their respective clinical programmes when used alongside reduced-calorie diet and increased physical activity. Your prescriber can help determine which option may be most suitable based on your individual medical history and treatment goals.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone called glucagon-like peptide-1. This hormone is naturally released by your intestines after eating and signals satiety to your brain. By activating GLP-1 receptors, Wegovy may help reduce appetite and promote feelings of fullness after smaller meals, potentially supporting weight management goals. The medication also slows gastric emptying, which can contribute to prolonged satiety between meals. Unlike Mounjaro, which targets both GLP-1 and GIP receptors, Wegovy focuses specifically on the GLP-1 pathway. This targeted approach has been extensively studied in the STEP clinical trial programme, demonstrating its potential effectiveness when used as part of a comprehensive weight management strategy.
Simple Online Ordering Process
Purchasing Wegovy through EverydayMeds involves a streamlined three-step process designed for patient convenience and clinical safety. First, complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Second, your assessment undergoes review by our qualified prescribers within 3 working days (or 24 hours with express service), ensuring appropriate clinical oversight. Third, once approved, your genuine Novo Nordisk Wegovy ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. This process ensures full compliance with MHRA regulations whilst providing rapid access to treatment. Our GPhC-registered pharmacy (#9012878) maintains strict quality standards, and all patients receive comprehensive injection guidance and ongoing support throughout their treatment journey.
Storage Advantages and Practical Considerations
When comparing whether Wegovy is cheaper than Mounjaro, consider practical factors beyond initial cost. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This extended stability provides greater travel convenience and reduces wastage risk. The FlexTouch pen system delivers precise dosing with clear visual confirmation of injection completion. Dose escalation follows a mandatory schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17. This structured progression helps minimise gastrointestinal side effects whilst optimising treatment outcomes.
Why UK Patients Choose Wegovy Over Mounjaro
Many UK patients find Wegovy's established track record and transparent pricing structure more appealing when asking "is Wegovy cheaper than Mounjaro?" The medication has been available longer, providing extensive real-world data on effectiveness and tolerability. Wegovy's single-mechanism approach (GLP-1 only) offers predictable effects, whilst Mounjaro's dual mechanism (GLP-1 + GIP) may introduce additional variables. The structured dose escalation prevents patients from progressing too quickly, reducing the likelihood of discontinuation due to side effects.
EverydayMeds' commitment to Wegovy supply chain reliability ensures consistent availability across all dose strengths, avoiding treatment interruptions that can occur with newer medications. Our comprehensive patient support includes injection technique guidance, storage advice, and ongoing clinical monitoring. The combination of competitive pricing, reliable supply, and established efficacy data makes Wegovy an attractive option for UK patients committed to long-term weight management success.
Start Your Wegovy Journey Today
Don't let pricing uncertainty delay your weight management goals - discover exactly how much your Wegovy treatment will cost with our transparent pricing structure. New customers save with discount code FIRST40, whilst returning patients use DOSE25, both applied automatically at checkout. Our clinical team is ready to assess your suitability and provide expert guidance on whether Wegovy represents the right investment for your health goals. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment today and join thousands of UK patients who've chosen our reliable, professional service. Remember, both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which prescription-only medicine aligns best with your individual circumstances and weight management objectives.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
